Pfizer, Inc. v. Biogen, Inc. > Summary
Court Case Number IPR2018-00285
Filing Date Dec 14, 2017
Institution Decision Date Jul 9, 2018
Decision Date Mar 27, 2019
Court Patent Trial and Appeal Board
Status Terminated-Settled
Administrative JudgesSheridan K. Snedden, Erica A. Franklin, Jacqueline T. Harlow
Judge Writing the Final DecisionSheridan K. Snedden
Claims Challenged in the Petition: 1
Claims Instituted: 1
Petitioner
Patent Owner
Petitioner Attorneys
11Pfizer Legal Division 2
Attorney Name: Eimeric Reig-Plessis
Winston & Strawn
Pfizer Legal Division 2
Attorney Name: Charles B. Klein
Winston & Strawn
Pfizer Legal Division 2
Attorney Name: Jovial Wong
Winston & Strawn
Pfizer Legal Division 2
Attorney Name: Dimitrios T. Drivas
White & Case
Pfizer Legal Division 2
Attorney Name: John P. Scheibeler
White & Case
Pfizer Legal Division 2
Attorney Name: Amit H. Thakore
White & Case
Pfizer Legal Division 2
Attorney Name: Leon Miniovich
White & Case
Pfizer Legal Division 2
Attorney Name: Eric A. Krause
White & Case
Pfizer Legal Division 2
Attorney Name: Allen W. Wang
White & Case
Pfizer Legal Division 2
Attorney Name: Robert J. Soiffer
Harvard University
Pfizer Legal Division 2
Attorney Name: Mark C. Benyunes
Genentech, Inc
Patent Owner Attorneys
9Biogen
Attorney Name: David I. Gindler
Irell & Manella LLP
Biogen
Attorney Name: Yite J. Lu
Irell & Manella LLP
Biogen
Attorney Name: Keith A. Orso
Irell & Manella LLP
Biogen
Attorney Name: Gary N. Frischling
Irell & Manella LLP
Biogen
Attorney Name: Michael R. Fleming
Irell & Manella LLP
Biogen
Attorney Name: Andrew E. Krause
Irell & Manella LLP
Biogen
Attorney Name: Alaina Bird
Irell & Manella LLP
Biogen
Attorney Name: Pia S. Kamath
Irell & Manella LLP
Biogen
Attorney Name: Leslie Oleksowicz
Irell & Manella LLP
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08329172 | Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody | Dec 11, 2012 |
